SCL:NYSEStepan Company Analysis

Stepan Company (SCL) is trading at $64.14, comfortably above its 20‑day SMA ($58.66) and 50‑day SMA ($55.50) while still below the 200‑day SMA ($51.37) trend line, indicating a strong short‑term bullish bias. The MACD histogram is positive (0.62) with a bullish signal line crossover, and volume is on an increasing trend, supporting the upward momentum. However, the 14‑day RSI sits at 69.8, edging into overbought territory, and the price is approaching the identified resistance level of $66.75, suggesting a potential short‑term pullback.
Fundamentally, SCL posted a Q2 net income of $22.9 M (≈$1.00 EPS) after a prior loss, and revenue grew 15% YoY to $2.43 B, but margins remain thin (gross 11.8%, operating 6.4%) and operating cash flow is flat at zero. The forward PE of 18.25 and price‑to‑book of 1.21 imply a fair valuation relative to peers, while the 2.46% dividend yield and 75% payout ratio are attractive but may be strained by a modest cash balance ($113 M) versus $563 M debt. The upside/downside estimate of +16.9% reflects the market’s optimism under an “Extreme Greed” sentiment, yet the negative ROE (‑0.2%) and high debt‑to‑equity (≈46%) underscore underlying financial risk.